Sodium-Glucose Cotransporter-2 (SGLT-2) Attenuates Serum Uric Acid (SUA) Level in Patients with Type 2 Diabetes

BACKGROUND: Hyperuricemia has a strong association with diabetes mellitus. Hyperuricemia can lead to cardiovascular and renal complications in patients with diabetes. The goal of this study was to compare the effect of sodium-glucose cotransporter-2 (SGLT-2) inhibitors dapagliflozin and empagliflozi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Mazhar, Elahi, Asim, Hussain, Abid, Iqbal, Javed, Akhtar, Lubna, Majid, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235989/
https://www.ncbi.nlm.nih.gov/pubmed/34239940
http://dx.doi.org/10.1155/2021/9973862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235989/
https://www.ncbi.nlm.nih.gov/pubmed/34239940
http://dx.doi.org/10.1155/2021/9973862

Ejemplares similares